Research sponsored by entities in developed countries, but conducted in developing countries, has recently been the focus of academic debate, international declarations and media controversy. Much of this attention has focused on whether the trials are exploitative and if so what should be done to avoid exploitation. This chapter takes Alan Wertheimer's principles of mutually advantageous transactions and applies them to the question of exploitation in international research. In this chapter, I develop an analysis of exploitation and apply this to the hypothesis that some pharmaceutical companies who run drug trials in developing countries wrongfully exploit the trial participants.
Ballantyne, A. (2006), "Chapter 10: Under What Conditions is Clinical Research in Developing Countries Exploitative? A Framework for Assessing Exploitation in Mutually Advantageous Transactions", Balint, J., Philpott, S., Baker, R. and Strosberg, M. (Ed.) Ethics and Epidemics (Advances in Bioethics, Vol. 9), Emerald Group Publishing Limited, Bingley, pp. 209-244. https://doi.org/10.1016/S1479-3709(06)09010-8Download as .RIS
Emerald Group Publishing Limited
Copyright © 2006, Emerald Group Publishing Limited